Volume 199, Issue 1, Pages (January 2018)

Slides:

Advertisements

Similar presentations

Randomized Trial of Percutaneous Tibial Nerve Stimulation Versus Sham Efficacy in the Treatment of Overactive Bladder Syndrome: Results From the SUmiT.

Advertisements

Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival Ryan K. Van Laar The.

CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB Martin J. Edelman, MD, Lydia.

Volume 188, Issue 4, Pages (October 2012)

Volume 187, Issue 6, Pages (June 2012)

Volume 155, Issue 3, Pages (March 1996)

MP60-03 PROSTATE CANCER IN THE ELDERLY

Hematocrit Response and Risk Factors for Significant Hematocrit Elevation with Implantable Testosterone Pellets Russell P. Hayden, Nelson E. Bennett,

Volume 195, Issue 4, Pages e13-e14 (April 2016)

Evaluation and Treatment of Lower Urinary Tract Symptoms in Older Men

Benjamin Herrick, Cameron Banga, Michael Phelps, Ronald Yap

Volume 105, Issue 3, Pages (March 1994)

Volume 195, Issue 5, Pages (May 2016)

The effect of perioperative chemotherapy for patients with an adenocarcinoma of the gastroesophageal junction: A propensity score matched analysis K.

Volume 27, Issue 4, Pages (December 2016)

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

The Male Factor in Fertility and Infertility. II

Volume 70, Issue 6, Pages (December 2016)

Volume 199, Issue 4, Pages e143-e144 (April 2018)

Cystic Nephroma of the Kidney

Seminal Vesicle Invasion by Adenocarcinoma of the Prostate

Oncocytoma of the Kidney

Volume 71, Issue 2, Pages (February 2017)

Mark H. Ebell, Taylor Radke, Jack Gardner The Journal of Urology

Volume 183, Issue 3, Pages (March 2010)

Volume 189, Issue 1, Pages (January 2013)

Volume 66, Issue 2, Pages (August 2014)

Volume 74, Issue 1, Pages (July 2018)

Volume 189, Issue 1, Pages S45-S50 (January 2013)

Volume 199, Issue 1, Pages (January 2018)

Pseudohyperplastic Adenocarcinoma of the Prostate

Volume 65, Issue 1, Pages (January 2014)

Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?

CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation Walid Saliba, MD, MPH, Gad Rennert,

Volume 184, Issue 4, Pages (October 2010)

Volume 185, Issue 6, Pages (June 2011)

Volume 199, Issue 4, Pages (April 2018)

Volume 185, Issue 2, Pages (February 2011)

Validation of the Stage Groupings in the Eighth Edition of the TNM Classification for Lung Cancer Xizhao Sui, MD, Wei Jiang, MD, Haiqing Chen, MD, Fan.

Volume 66, Issue 2, Pages (August 2014)

Volume 74, Issue 2, Pages (August 2018)

Prostate-Specific Antigen Kinetics and Outcomes in Patients with Bone Metastases from Castration-Resistant Prostate Cancer Treated with or Without Zoledronic.

Appendectomy is followed by increased risk of Crohn's disease

Patient and Graft Survival Following Kidney Transplantation in Recipients With Cystinosis: A Cohort Study Rebecca A. Spicer, MBChB, Philip A. Clayton,

Three Versus 4 Daily Exchanges and Residual Kidney Function Decline in Incident CAPD Patients: A Randomized Controlled Trial Hao Yan, MD, Wei Fang, MD,

Carotid endarterectomy in patients less than 50 years old

Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases Haifeng Wang, MM, Hongsheng Lin, MM, Gening.

A Combined Prognostic Serum Interleukin-8 and Interleukin-6 Classifier for Stage 1 Lung Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening.

Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?

Kaplan-Meier curves comparing: (A) overall survival for patients treated on trial compared to those outside of a trial; (B) progression-free survival for.

Impact of Positive Nodal Metastases in Patients with Thymic Carcinoma and Thymic Neuroendocrine Tumors Benny Weksler, MD, Anthony Holden, MD, Jennifer.

Elevated Fibroblast Growth Factor 23 in a Patient With Metastatic Prostate Cancer and Hypophosphatemia Casey L. Cotant, MD, Panduranga S. Rao, MD, DNB,

Axel Heidenreich European Urology Supplements

Volume 373, Issue 9658, Pages (January 2009)

Efficacy and Safety of Bevacizumab-Based Therapy in Elderly Patients with Advanced or Recurrent Nonsquamous Non-small Cell Lung Cancer in the Phase III.

Phase II Study of the Histone Deacetylase Inhibitor Romidepsin in Relapsed Small Cell Lung Cancer (Cancer and Leukemia Group B 30304) Gregory A. Otterson,

Is the B12/CRP Index More Accurate Than You at Predicting Life Expectancy in Advanced Cancer Patients? Filipa Tavares, MD Journal of Pain and Symptom.

Volume 68, Issue 5, Pages (November 2015)

Pulmonary Resection for Metastases from Colorectal Cancer

American Journal of Kidney Diseases

Michael Hsie, MD, Stefania Morbidini-Gaffney, MD, Leslie J

Impact of Tumor Size on Local Control and Pneumonitis After Stereotactic Body Radiation Therapy for Lung Tumors Sean M. Parker, BS, R. Alfredo Siochi,

Axel Heidenreich European Urology Supplements

Safety and Efficacy of First-Line Bevacizumab Plus Chemotherapy in Elderly Patients with Advanced or Recurrent Nonsquamous Non-small Cell Lung Cancer:

APLCC POSTER SESSION 2 - WEDNESDAY, NOVEMBER 28

Kaplan-Meier curves for PFS (panel A) and OS (panel B) of patients with mTCC receiving an anti-EGFR based therapy. mTCC, metastatic transverse colon cancer;

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Clinical Efficacy and Predictive Molecular Markers of Neoadjuvant Gemcitabine and Pemetrexed in Resectable Non-small Cell Lung Cancer Gerold Bepler,

A Randomized Phase II Trial Assessing in Advanced Non-small Cell Lung Cancer Patients with Stable Disease after Two Courses of Cisplatin-Gemcitabine an.

Kristin A. Higgins, MD, Junzo P. Chino, MD, Neal Ready, MD, Mark W

Presentation transcript:

Volume 199, Issue 1, Pages 147-154 (January 2018) Efficacy and Safety of Enzalutamide vs Bicalutamide in Younger and Older Patients with Metastatic Castration Resistant Prostate Cancer in the TERRAIN Trial D. Robert Siemens, Laurence Klotz, Axel Heidenreich, Simon Chowdhury, Arnauld Villers, Benoit Baron, Steve van Os, Nahla Hasabou, Fong Wang, Ping Lin, Neal D. Shore The Journal of Urology Volume 199, Issue 1, Pages 147-154 (January 2018) DOI: 10.1016/j.juro.2017.08.080 Copyright © 2018 American Urological Association Education and Research, Inc. Terms and Conditions

Figure 1 Kaplan-Meier curve of progression-free survival on enzalutamide (ENZA) and bicalutamide (BIC) by age group. Radiographic disease progression component was assessed by independent central review. The Journal of Urology 2018 199, 147-154DOI: (10.1016/j.juro.2017.08.080) Copyright © 2018 American Urological Association Education and Research, Inc. Terms and Conditions

Figure 2 Kaplan-Meier plot of time to prostate specific antigen progression for enzalutamide (ENZA) and bicalutamide (BIC) by age group. The Journal of Urology 2018 199, 147-154DOI: (10.1016/j.juro.2017.08.080) Copyright © 2018 American Urological Association Education and Research, Inc. Terms and Conditions